Targeting tumor redox homeostasis, via inhibition of GSH/SOD2 biosynthesis or induction of their metabolic depletion, represents a promising therapeutic strategy to potentiate anticancer drug efficacy [16]. This evidence concerns the gene SOD2 and neoplasm.